Definition

  • Benign salivary gland tumour

Epidemiology

  • Rare <1%
  • 2nd most common benign parotid gland tumour
  • M>F

Risk Factor

  • SMOKING (only salivary gland tumour associated to smoking)
  • Others
    • Radiation
    • EBV

Location

  • Parotid (almost exclusively)

Features

  • Commonly cystic and bilateral

Pathology

  • Macro
    • Well circumscribed mass
    • Solid and cystic components
  • Micro
    • Bilayered oncocytic epithelium
    • Cyst formation
    • Lymphoid stroma

Clinical

  • Painless lump near angle of mandible

Investigations

  • Assess both sides - bilaterality and multiple
  • USS - well defined mass, anechoic areas, post acoustic shadowin
  • CT - bony involvement
  • MRI - soft tissue involvement, encapsulated, hypo T1
  • Biopsy - FNA or core

Management

  • Usually superficial parotidectomy
  • Surveillance if biopsy proven and not changing, asymptomatic
    • Low recurrence rate and minimal malignant potential

Spiel on Warthin’s tumour

  • 2nd most common benign salivary tumour
  • Affects almost exclusively the parotid gland
  • Typified by bilayered oncocytic epithelium, cyst formation and lymphoid stroma
  • RF - SMOKING, prior RTX, viral (EBV/HPV/HIV) and exposures - nickel, rubber, hairdresser
  • Minimal risk of malignant transformation
  • Can avoid surgery and monitor if no sx
  • Presents with painless lump
  • Work up with USS/CT/MRI and FNA/core
  • Mx is superficial parotidectomy and facial nerve preservation
  • Minimal benefit for doing total even if deep component is involved